Courier Capital’s iShares Biotechnology ETF IBB Stock Holding History

Courier Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$479K	Hold	2,517	–	–	0.02%	292
2026 Q1	$425K	Hold	2,517	–	–	0.02%	295
2025 Q4	$425K	Hold	2,517	–	–	0.02%	289
2025 Q3	$363K	Sell	2,517 -100	-4%	-$13.7K	0.02%	310
2025 Q2	$331K	Hold	2,617	–	–	0.02%	317
2025 Q1	$335K	Sell	2,617 -20	-0.8%	-$2.71K	0.02%	302
2024 Q4	$349K	Sell	2,637 -5,700	-68%	-$801K	0.02%	296
2024 Q3	$1.21M	Sell	8,337 -225	-3%	-$32.6K	0.08%	181
2024 Q2	$1.18M	Hold	8,562	–	–	0.09%	161
2024 Q1	$1.17M	Hold	8,562	–	–	0.09%	178
2023 Q4	$1.16M	Hold	8,562	–	–	0.09%	172
2023 Q3	$1.05M	Hold	8,562	–	–	0.09%	172
2023 Q2	$1.09M	Hold	8,562	–	–	0.09%	170
2023 Q1	$1.11M	Buy	8,562 +219	+3%	+$28.7K	0.12%	116
2022 Q4	$1.1M	Sell	8,343 -66	-0.8%	-$8.53K	0.13%	117
2022 Q3	$984K	Hold	8,409	–	–	0.12%	121
2022 Q2	$989K	Hold	8,409	–	–	0.12%	123
2022 Q1	$1.1M	Sell	8,409 -660	-7%	-$86K	0.11%	124
2021 Q4	$1.38M	Buy	9,069 +60	+0.7%	+$9.29K	0.13%	116
2021 Q3	$1.46M	Hold	9,009	–	–	0.14%	111
2021 Q2	$1.47M	Hold	9,009	–	–	0.14%	112
2021 Q1	$1.36M	Hold	9,009	–	–	0.14%	112
2020 Q4	$1.36M	Hold	9,009	–	–	0.15%	108
2020 Q3	$1.24M	Hold	9,009	–	–	0.15%	108
2020 Q2	$1.25M	Hold	9,009	–	–	0.16%	104
2020 Q1	$1.1M	Hold	9,009	–	–	0.16%	100
2019 Q4	$1.09M	Hold	9,009	–	–	0.13%	111
2019 Q3	$890K	Sell	9,009 -100	-1%	-$10.5K	0.12%	120
2019 Q2	$994K	Hold	9,109	–	–	0.13%	116
2019 Q1	$1.02M	Hold	9,109	–	–	0.13%	116
2018 Q4	$878K	Hold	9,109	–	–	0.13%	117
2018 Q3	$1.11M	Sell	9,109 -110	-1%	-$13K	0.14%	121
2018 Q2	$1.01M	Hold	9,219	–	–	0.13%	125
2018 Q1	$984K	Sell	9,219 -940	-9%	-$104K	0.13%	122
2017 Q4	$1.08M	Buy	+10,159	New	+$1.09M	0.14%	116
2017 Q3	–	Sell	-10,239	Closed	-$1.06M	–	284
2017 Q2	$1.06M	Hold	10,239	–	–	0.18%	104
2017 Q1	$1M	Hold	10,239	–	–	0.18%	107
2016 Q4	$906K	Sell	10,239 -504	-5%	-$45.9K	0.17%	107
2016 Q3	$1.04M	Sell	10,743 -36	-0.3%	-$3.42K	0.21%	93
2016 Q2	$925K	Buy	10,779 +36	+0.3%	+$3.23K	0.18%	102
2016 Q1	$934K	Sell	10,743 -720	-6%	-$64.4K	0.19%	94
2015 Q4	$1.29M	Hold	11,463	–	–	0.28%	77
2015 Q3	$1.16M	Sell	11,463 -39	-0.3%	-$4.68K	0.26%	84
2015 Q2	$1.42M	Hold	11,502	–	–	0.28%	81
2015 Q1	$1.32M	Hold	11,502	–	–	0.26%	87
2014 Q4	$1.16M	Sell	11,502 -825	-7%	-$80.2K	0.23%	93
2014 Q3	$1.12M	Buy	12,327 +456	+4%	+$40K	0.23%	101
2014 Q2	$1.02M	Buy	11,871 +105	+0.9%	+$8.27K	0.2%	108
2014 Q1	$927K	Buy	11,766 +1,470	+14%	+$122K	0.19%	109
2013 Q4	$779K	Buy	10,296 +1,830	+22%	+$130K	0.17%	117
2013 Q3	$591K	Hold	8,466	–	–	0.14%	133
2013 Q2	$491K	Buy	+8,466	New	+$489K	0.12%	142

Other funds holding IBB

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return

FMI

Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Courier Capital's IBB Position: Q2 2026 in Review

Courier Capital held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,517 shares worth $479K. The position accounts for 0.02% of the portfolio, ranked #292.

Courier Capital first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.47M in Q2 2021. 415 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Courier Capital held 2,517 shares of iShares Biotechnology ETF worth $479K as of Q2 2026.
Courier Capital left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.02% of Courier Capital's portfolio in Q2 2026, its #292 holding.
Courier Capital first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
Courier Capital's iShares Biotechnology ETF position peaked at $1.47M in Q2 2021.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.